Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Fraga

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|February 5, 2003
Synthesis and pharmacological evaluation of novel antinociceptive N-substituted-phenylimidazolyl-4-acylhydrazone derivativesAnna C Cunha, Jorge L M Tributino, Ana L P Miranda, et al.
Current Topics in Medicinal Chemistry|October 30, 2019
The Use of Conformational Restriction in Medicinal ChemistryPedro de Sena M Pinheiro, Daniel A Rodrigues, Rodolfo do Couto Maia, et al.
Medicinal Research Reviews|June 27, 2020
Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunitiesDaniel A Rodrigues, Pedro de S M Pinheiro, Fernanda S Sagrillo, et al.
European Journal of Medicinal Chemistry|February 23, 2002
New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidatesNilda M Silva, Jorge L M Tributino, Ana L P Miranda, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-Methyl-7-(4-nitro-phen-yl)-3-phenyl-pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine-6,8(3H,7H)-dioneJose R Sabino, Cecília M A Oliveira, Carlos A M Fraga, et al.
Journal of Molecular Modeling|September 9, 2011
Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazoneRodolpho C Braga, Vinícius M Alves, Carlos A M Fraga, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro ProfileRaysa Magali Pillpe-Meza, Wesley Leandro Gouveia, Gisele Barbosa, et al.
Bioorganic & Medicinal Chemistry|April 26, 2005
Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analoguesAlexandre G Silva, Gisele Zapata-Sudo, Arthur E Kummerle, et al.
Behavioural Pharmacology|October 30, 2015
LASSBio-579, a prototype antipsychotic drug, and clozapine are effective in novel object recognition task, a recognition memory modelCamila B Antonio, Andresa H Betti, Vivian Herzfeldt, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2005
The molecular basis for coxib inhibition of p38alpha MAP kinaseGilberto M Sperandio da Silva, Lidia M Lima, Carlos A M Fraga, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Farmaco (Societa Chimica Italiana : 1989)|February 5, 2003
Synthesis and pharmacological evaluation of novel antinociceptive N-substituted-phenylimidazolyl-4-acylhydrazone derivativesAnna C Cunha, Jorge L M Tributino, Ana L P Miranda, et al.
Current Topics in Medicinal Chemistry|October 30, 2019
The Use of Conformational Restriction in Medicinal ChemistryPedro de Sena M Pinheiro, Daniel A Rodrigues, Rodolfo do Couto Maia, et al.
Medicinal Research Reviews|June 27, 2020
Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunitiesDaniel A Rodrigues, Pedro de S M Pinheiro, Fernanda S Sagrillo, et al.
European Journal of Medicinal Chemistry|February 23, 2002
New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidatesNilda M Silva, Jorge L M Tributino, Ana L P Miranda, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-Methyl-7-(4-nitro-phen-yl)-3-phenyl-pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine-6,8(3H,7H)-dioneJose R Sabino, Cecília M A Oliveira, Carlos A M Fraga, et al.
Journal of Molecular Modeling|September 9, 2011
Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazoneRodolpho C Braga, Vinícius M Alves, Carlos A M Fraga, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro ProfileRaysa Magali Pillpe-Meza, Wesley Leandro Gouveia, Gisele Barbosa, et al.
Bioorganic & Medicinal Chemistry|April 26, 2005
Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analoguesAlexandre G Silva, Gisele Zapata-Sudo, Arthur E Kummerle, et al.
Behavioural Pharmacology|October 30, 2015
LASSBio-579, a prototype antipsychotic drug, and clozapine are effective in novel object recognition task, a recognition memory modelCamila B Antonio, Andresa H Betti, Vivian Herzfeldt, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2005
The molecular basis for coxib inhibition of p38alpha MAP kinaseGilberto M Sperandio da Silva, Lidia M Lima, Carlos A M Fraga, et al.
Pageof 12